Alok Srivastava, is Senior Professor in the Department of Haematology, Christian Medical College (CMC), Vellore, India and Head of the Centre for Stem Cell Research, a unit of Institute of Stem Cell Research and Regenerative Medicine (inStem), Bengaluru, at Vellore.
Prof. Srivastava has been involved with clinical haematopoietic stem cell transplantation (HSCT) at CMC, Vellore in India for nearly three decades. Over the last fifteen years, he has also established the Centre for Stem Cell Research which is focused on translational research to develop novel cell and gene therapies.
He is the President of the Indian Society for Blood and Marrow Transplant and also the Chairman of the Executive Board of the Asia Pacific Blood and Marrow Transplant Group. He is the chair of the Technical Evaluation Committee for human genetics, genome engineering and nano technology applications of the Department of Biotechnology of the Ministry of Science and Technology, Government of India.
Prof. Srivastava’s research interests in this field have haematopoietic stem cell transplantation, haemostasis disorders and gene therapy. His group has developed novel technologies for gene therapy for haemophilia and the major haemoglobin disorders – thalassemia major and sickle cell disease. He has initiated a first-in-human lentiviral vector mediated haemtopoietic stem cell-based gene therapy for haemophilia A in India. He has over 400 peer reviewed scientific publications.
|